Octreotide extended-release: CHEMI S.p.A.Alternative Names: LF-PB; Octreotide acetate - Chemi S.p.A.
Latest Information Update: 14 Feb 2017
Price : $50
At a glance
- Originator CHEMI S.p.A.
- Class Antineoplastics; Antisecretories; Cyclic peptides; Indoles; Somatostatins
- Mechanism of Action Growth hormone releasing factor antagonists; Somatostatin receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Inflammation
Most Recent Events
- 01 Oct 2015 Phase-II clinical trials in Inflammation in Italy (IM) (NCT02668588)
- 07 Aug 2013 Biomarkers information updated
Table of Contents
- At a glance
- Development Overview
- Drug Properties & Chemical Synopsis
- Trial Landscape
- Development Status
- Commercial Information
- Related Safety Reports
- Development History